CCNE1 and ovarian carcinoma: In the primary screen of ovarian cancer cells with CCNE1-amplification, 48 h after transfection of the Dharmacon kinome library we first monitored cell viability and Caspase-3/7 activities of OVCAR-3 cells in a multiplexed assay (Supplementary Figure 2A-2C).